Please wait

ONCORUS, INC.

50 Hampshire Street, Suite 401

Cambridge, Massachusetts 02139

February 9, 2021

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

 

Attn:

Ms. Nudrat Salik

 

Mr. Daniel Gordon

 

Ms. Abby Adams

 

Ms. Irene Paik

 

  RE:

Oncorus, Inc.

   

Registration Statement on Form S-1

   

File No. 333-252896

Ladies and Gentlemen:

Oncorus, Inc. (the “Registrant”) hereby requests that the U.S. Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-1 to become effective on February 11, 2021, at 4:40 p.m., Eastern Time, or as soon thereafter as is practicable or at such later time as the Registrant may orally request via telephone call to the staff of the Commission. The Registrant hereby authorizes each of Brian F. Leaf and Courtney T. Thorne of Cooley LLP, counsel to the Registrant, to make such request on its behalf.

Once the Registration Statement has been declared effective, please orally confirm that event with Brian F. Leaf of Cooley LLP, counsel to the Registrant, at +1 703 456 8053, or in his absence, Courtney T. Thorne at +1 617 937 2318.

[Signature Page Follows]


Very truly yours,

 

ONCORUS, INC.

By:   /s/ Ted Ashburn
Name:   Theodore (Ted) Ashburn, M.D., Ph.D.
Title:   President and Chief Executive Officer

 

cc:

John McCabe, Oncorus, Inc.

Marc A. Recht, Cooley LLP

Brian F. Leaf, Cooley LLP

Courtney T. Thorne, Cooley LLP

Lisa Firenze, Wilmer Cutler Pickering Hale and Dorr LLP

Jeffries Oliver-Li, Wilmer Cutler Pickering Hale and Dorr LLP